ABSTRACT Poly(phenolic)-sulfonates demonstrated very good cytotoxicity against the growth of tumor cell lines (L1210, Tmolt-3, HeLa-S3) and are comparable in potency with typical clinically used anticancer drugs. Four of the most active compounds, i.e. GL-2021, GL-2029, GL-2041 and GL-2063, were selected for a mode of action study in L1210 lymphoid leukemia cells at concentration of 25ktM to 100M for 60 min.
INTRODUCTION
Large molecular weight polymers, e.g. sulfated polysaccharide dextran sulfate, pentosan polysulfate, have demonstrated anti-HIV-1 and anti-HIV-2 activity by interfering with binding of the gp 120 protein to CD4 and blocking reverse transcriptase activity 1]. Hepsulfam, a new antineoplastic alkanesulfonate agent, has demonstrated a broad preclinical activity in human tumor xenografts [2, 3] and oat cell lung cancer; however, this agent exhibited in vitro toxicity in human bone marrow cells [3] . Suramin, a known antitrypanosomal agent, was found to exert a strong inhibitory effect on RNA-directed DNA polymerase (reverse transcriptase) activity of several oncornaviruses such as Moloney murine leukemia virus, murine Rauscher leukemia viruses, Moloney murine sarcoma virus and avian myeloblastosis viruses [4] [5] [6] [7] . Related to suramin is a class of sulfonic acid azo dyes, for example, Evans blue, which has been shown to be active against replication of the AIDS virus [6] . Recently a series of poly(phenolic)sulfonated compounds were shown to have potent anti-inflammatory activity and protection against induced endotoxic shock in mice at 8 and 16 mg/kg, I.P [8] . These agents prove to be potent elastase and prostaglandin cyclooxygenase inhibitors, blocking the release of TNFt and IL-1 release. The binding of these cytokines to high affinity receptors on their target cells were also competitively suppressed by the agents. These compounds blocked the adhesion of leukocytes and macrophages to L929 fibroblasts grown in tissue culture [5] . Because of these properties it was surmised that these poly(phenolic)sulfonated compounds may have antineoplastic activity. [14] . The DNA polymerase assay was described by Sedwick et al. [15] using 3H-TTP. Messenger-, ribosomal-and transfer-RNA polymerase enzymes were isolated with different concentrations of ammonium sulfate;
METHODS
individual RNA polymerase activities were determined using 3H - UTP 16, 17] . Ribonucleoside reductase activity was measured using 4C -CDP with dithioerythritol [18] . The deoxyribonucleotides 4C -dCDP were separated from the ribonucleotides by TLC on PEI plates. Thymidine, TMP and TDP kinase activities were determined using 3H -thymidine (58.3 mCi/mmol) in the medium of Maley and Ochoa [19] .
Carbamyl phosphate synthetase activity was determined with the method of Kalman et al. [20] and citrulline was determined colorimetrically [21] . Aspartate transcarbamylase activity was measured using the incubation medium of Kalman et al. [20] , carbamyl aspartate was determined colorimetrically by the method of Koritz et aL [22] . Thymidylate synthetase activity was analyzed by Kampf et al. 's method [23] . 
Statistical Test
In Tables 3-6 , the data is represented as the average of the percent of control and the standard deviations.
In Fig 2-12 , all standard deviations are within 5.2% of the value. The probable significant different [p] between the treated raw data and the control raw data for each assay was determined using the Student's "t" test.
RESULTS
The I.tM. m-RNA polymerase activity was reduced 50% to 60% and t-RNA polymerase activity was reduced 24% to 41% at 100 laM over hr. r-RNA polymerase activity was elevated slightly by G1-2021 20% to 23% after hr from 25 to 100 ktM, but the other three agents had no significant effect on this enzyme activity. 6.94 pmol Ribonucleoside reductase activity was not reduced by any of the four poly(phenolic)sulfonates over hr but rather it was stimulated significantly particularly at the lower concentrations after this time period. Dihydrofolate reductase activity was reduced only by compounds G1-2021 by 24% and G1-2063 by 46% at 100 t.tM after hr. L1210 de novo purine synthesis was suppressed 18% to 46% at 100 ktM of poly(phenolic)sulfonates over hr with the activities of regulatory enzyme PRPP amido transferase activity being suppressed 61% to 90% and IMP dehydrogenase activity being reduced 23% to 34% at 100 tM over hr. In all three of these assays the agents demonstrated a concentration dependent suppression of activity. De novo pyrimidine synthesis was not significantly reduced by the agents at these concentrations for hr. Carbamylate phosphate synthetase activity was reduced 27% to 38% at 100 M after hr. But aspartate transcarbamylase activity was not affected by the compounds, significantly. Thymidylate synthetase activity was reduced marginally 8% to 18% at 100 txM after hr. Thymidine kinase activity was suppressed 12% to 24%, TMP kinase activity was reduced 63% to 68%, TDP kinase activity was inhibited 46% to 74% after hr at 100 laM. Again With two of the compounds, i.e. GI-2021 and G1-2029, activity remained suppressed at 60 and 90 min.
[ Fig 7] while with GI-2041 and G1-2063 the DNA polymerase activity returned to normal at 90 min. L1210 m-RNA polymerase activity was significantly reduced after 30 min, but with increasing times of incubation achieved the lowest value, e.g. 50% to 60% at 120 min. [Fig 8 ] . PRPP-amido transferase activity was significantly reduced greater tha 60% aider 60 min and remained consistently suppressed over the next 2 hr. [Fig 9] . Thymidine kinase activity was only marginally inhibited at 90 min and required 2 hr to observe at least 40% inhibition of activity [ Fig 10] . TMP kinase activity demonstrated marked reduction at 60 min but the activity recovered at 90 and 120 min [ Fig 11 ] . TDP kinase activity was erratic also with the highest reduction at 60 min but again the activity recovered after 90 min [Fig 12] . [35] [36] [37] . Kinetic growth studies demonstrated that the poly(phenolic)sulfonate agents were cytostatic as opposed to cytocidal and they did not follow a concentration dependent inhibition of growth of L1210 cells [from M] at higher concentrations of the agents. This could be due to saturation of cellular transport processes by the agent or saturation of the key target receptor by the agent for inducing cell death. It is interesting to note that suramin, a hexasulfated naphthylurea, required a concentration of 250 l.tg/ml or 1.75 mM in HeLa cells to cause death and required 40 laM to inhibit SV40 replication in HeLa cells [38] . The growth of human lung cancers PC-9, and H69 and their resistant strains to cisplatin or etoposide was suppressed by suramin at 60 to 400 ktg/ml [39] . In Chinese hamster growth DC-3F and DC-3F/9-OH-E (resistant 9-hydroellipticine subline)
DISCUSSION
EDs0 values for suramin were 31 ktM and 203 ktM [41 ] . GI-2029 ;, GI-2041 ,GI-2063 The "n" number of the compound being 6 or 8 did not seem to explain the difference observed for the IC50 values for enzyme inhibition. Certainly even after 60 min the purine deoxyribonucleotides were generally reduced but the effects on pyrimidine deoxyribonucleotides were not in evidence at this time of incubation. L1210 ribonucleoside reductase activity was not affected by the agents; thus, the conversion from ribonucleotides to deoxyribonucleotides was not a factor in the mode of action of these agents. [7] . Since L1210 RNA synthesis was marginally reduced by the poly(phenolic)sulfonates over the 60 min period at 100 l.tM, this was probably the result of the reduction in ribonucleotides due to the reduction in de novo purine synthesis by these agents. This does not appear to be a major site of action of the derivatives which would be responsible for cell death or apoptosis. [41] . L1210 lymphoid leukemia DNA fragmentation did occur after 24 hours incubation using whole cells. Suramin has been shown to be a DNA topoisomerase II inhibitor in PC-9 lung cancer cells and Chinese hamster fibrosarcoma cells [41] . It is possible that poly(phenolic)sulfonates function by this method also to afford DNA fragmentation. Evidence would suggest from the findings of the studies on poly(phenolic)sulfonates that they have a dual mechanism of action on cancer cells. These studies have already demonstrated that these derivatives suppress polymerase and PRPP-amido transferase activities in L 1210 lymphoid leukemia cells. These studies have demonstrated that poly(phenolic)sulfonates have characteristics of the antineoplastic agents similar to suramin which has been used in advanced human malignant cancers that are refractory to standard cancer chemotherapy [43] . Whereas the studies with poly(phenolic)sulfonates are in their initial stages and certainly additional studies are warranted, and since they have demonstrated more potency in a number of these biochemical assays than suramin, they may have potential in the future as clinical agents to treat cancer patients.
